Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Covalent inhibitors of menin-MLL interaction for diabetes mellitus

Covalent inhibitors of menin-MLL interaction for diabetes mellitus

US Patent 12251385 · Granted Mar 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of menin-MLL interaction2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Pheny2025
Substituted pyridines as irreversible inhibitors of menin-MLL interaction2024
Irreversible inhibitors of menin-MLL interaction2024
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phe2024
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phe2024
Pyrazine compounds as inhibitors of FLT32024
Pyrazine compounds as inhibitors of FLT32024
Heterocyclic inhibitors of PCSK92024
Inhibitors of menin-mll interaction2023
Substituted pyridines as irreversible inhibitors of menin-MLL interaction2023
Inhibitors of menin-MLL interaction2021